Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Proof-of-concept study to determine the feasibility of measuring bacterial load in exhaled breath of children with pneumonia and empyema using a novel point-of-care test
5th International Congress on Infectious Diseases
Gladys Makuta, Colin Powell, Bastiaan Hoogendoorn, Clive Gregory, Jenna Bowen and Rhiannon Phillips
Background: Pneumonia is a leading cause of death in children. Approximately 75% of patients with acute respiratory tract infections (ARTI) receive antibiotics despite most of these infections having viral origin. Early diagnosis and appropriate treatment is essential. There is no point-of-care (POC) test, available to diagnose bacterial pneumonia. This study aims to investigate the feasibility of developing a POC device that will measure bacterial load in breath from children with pneumonia and empyema. The purpose is to find a diagnostic POC test capable of isolating bacterial pneumonia. Methods: This study is designed to show that a POC breath test can detect the difference in bacterial load (through assay of lipopolysaccharide (LPS) and peptidoglycan) in exhaled breath of children with pneumonia/empyema and those without a chest infection (controls). It comprises of development of a breath sampler, laboratory and clinical testing. Three prototypes of the breath sampler were produced in phases with refinement. Each prototype underwent laboratory testing using a known concentration of endotoxin which was nebulized thorough the prototype incorporating a sampling surface (SS). Subsequently, a sample of endotoxin impinged on the SS was extracted and tested using limulus amebocyte lysate (LAL) assay. Clinical testing involves collecting breath samples from 48 children between 5 to 15 years with pneumonia/empyema and well matched controls. Semi-structured qualitative interviews will be conducted with participants, parents and clinicians to examine the acceptability of the test. Results: A breath sampler, suitable for clinical testing has been developed. Results from laboratory testing show that it is possible to detect nebulized endotoxins (comparable to levels detectable in breath) using the LAL assay. Discussion & Conclusion: The study will demonstrate the potential of using a POC test to identify children with pneumonia or empyema who may benefit from antibiotics. References 1. Shah S N, et al., (2017) Does This Child Have Pneumonia?: the rational clinical examination systematic review. Jama 318(5):462-471. 2. Schuetz P, et al., (2009) Effect of procalcitonin-based guidelines vs. standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. Jama 302(10):1059-1066. 3. Wootton D and C Feldman (2014) The diagnosis of pneumonia requires a chest radiograph (X-ray)ΓΆΒ?Β?yes, no or sometimes? Pneumonia 5(1):1. 4. Bartlett J G (2011) Diagnostic tests for agents of community-acquired pneumonia. Clinical Infectious Diseases 52(4):S296-S30.
Biography
Gladys Makuta completed her MSc in International Health and Management and BA in Health Sciences and Social Services. She is currently a PhD student in the Division of Population Medicine at Cardiff University, United Kingdom, working on the balloon study. She has strong research interest in infection detection, prevention and management in a global health context. She has significant experience in commercial and non-commercial clinical research and teaching gained from both developed and resource limited areas, prior to her current role.
Email:MakutaG@cardiff.ac.uk
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals